In the Boardroom
Refine Search
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Pharmaceutical
Growing revenues and profitability in step with pipeline development, British drugmaker AstraZeneca posted an upbeat second quarter results statement on Thursday, with a strong focus on efforts to combat the novel coronavirus. 30 July 2020
Pharmaceutical
Despite second quarter sales being undercut by the coronavirus pandemic, French drugs and vaccines specialist Sanofi has raised its projection for the year, spurred by cost cutting measures and the sale of its stake in Regeneron Pharmaceuticals. 29 July 2020
Pharmaceutical
LEO Pharma’s UK and Ireland business has appointed a new medical affairs lead, Amit Aggarwal, formerly director of UK medical affairs at Bayer. 23 July 2020
Pharmaceutical
Following the appointment of Haseeb Ahmad to the role of global head of value and access and commercial development, Chinmay Bhatt has taken on the position of managing director UK, Ireland & Nordics for Novartis. 21 July 2020
Pharmaceutical
Denmark-headquartered Abacus Medicine is set to acquire Dutch pharmaceutical wholesaler Pluripharm Group. 13 July 2020
Pharmaceutical
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Dr Monica Shaw and Nathalie Joannes will join the executive leadership team adding seasoned experience and international profile to the company. 1 July 2020
Pharmaceutical
UK-based Indivior’s shares rose nearly 4% to 79.05 pence in early trading, after it announced that, effective today, Mark Crossley is appointed chief executive. However, the stock was down 1% at 78.00 pence by late morning. 29 June 2020
Pharmaceutical
The European Medicines Agency (EMA) Management Board has announced its nomination for the new executive director of the Agency to replace the outgoing Professor Guido Rasi, who is due to end his term in the position that he has held since 2011 (minus an off-stint due to a controversy over the selection procedure). 25 June 2020
Pharmaceutical
Mundipharma today announced that Marc Princen has joined the Mundipharma network of independently associated companies as the global chief executive, effective June 1, 2020. 15 June 2020
Pharmaceutical
As part of an R&D overhaul, Copenhagen-based CNS specialist Lundbeck has announced plans to reduce its headcount by around 150, mostly in Denmark. 9 June 2020
Pharmaceutical
On Friday, US President Donald Trump announced the addition of two of the most highly respected and skilled professionals to the White House new initiative, dubbed Operation Warp Speed, the objective of which is to finish developing and then to manufacture and distribute a proven coronavirus vaccine as fast as possible. 16 May 2020
Pharmaceutical
Swiss pharma giant Roche today announced that, on May 10, Dr Fritz Gerber, a formative figure in the company’s history, died in his 92nd year. 11 May 2020
Pharmaceutical
New Jersey, USA-based rare disease drug developer PTC Therapeutics today announced the appointments of Matthew Klein to chief development officer and Eric Pauwels to chief business officer. 17 April 2020
Pharmaceutical
H3 Biomedicine, the USA-based precision medicine subsidiary of Japanese drugmaker Eisai, has named industry veteran Antonio Gualberto its chief medical officer (CMO). 20 February 2020
Pharmaceutical
German drugmaker Stada Arzneimittel has appointed Wolfgang Ollig as group chief financial officer (CFO) with effect from February 1, 2020. 31 January 2020
Pharmaceutical
A better-than-forecast financial results statement has sent Eli Lilly stock climbing nearly 1.5% in pre-market trading. Shares were already up 0.47% after strong trading on Wednesday. 30 January 2020
Pharmaceutical
French drugmaker Ipsen has appointed a new chief medical officer, former Merck Serono CMO Steven Hildemann. 14 January 2020
Pharmaceutical
USA-based AMAG Pharmaceuticals is losing not just its chief executive, but also two of its marketed drugs, the company has said. 10 January 2020
Pharmaceutical
Ahead of completing its $63 billion buy of Ireland-incorporated Allergan, AbbVie today announced the creation of a new global business, Allergan Aesthetics, an AbbVie company, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition. 8 January 2020
Pharmaceutical
Mene Pangalos, one of the leaders behind AstraZeneca’s remarkable recent record of successful drug development, has been awarded a knighthood. 31 December 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze